chevron_leftBack
As of 24 April 2025, Laurus Labs Ltd. has a market cap of $4.11B USD, ranking #3281 globally and #230 in India. It ranks #279 in the Healthcare sector, and #45 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$4.11BUSD
351.43B INR
Enterprise Value
$4.43BUSD
378.97B INR
Revenue (TTM)
$617.31MUSD
52.73B INR
EBITDA (TTM)
$101.38MUSD
8.67B INR
Net Income (TTM)
$23.44MUSD
2.0B INR
EBITDA Margin
16%
Profit Margin
3.8%
PE Ratio
176.1
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Satyanarayana Chava
open_in_new
Employees
6,007
Founded
2005
Website
lauruslabs.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.2% | 3.5% | 6.2% | 14% | 45% | 51% |
Upcoming Earnings
Earnings Date
Fri, Apr 25
Tomorrow
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
LAURUSLABS
Laurus Labs Ltd
ISIN: INE947Q01028
Shares Out.:
Shares Outstanding:
539.253M1
Shares Float:
357.397M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
650.70 INR | |
|
540222
(LAURUSLABS)
Laurus Labs Ltd
ISIN: INE947Q01028
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
650.45 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Laurus Labs Ltd.
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides oral solid formulations for ARVs, anti-diabetic, cardiovascular, and PPIs. In addition, the company offers contract development and manufacturing organizational services; and biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. Further, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
